Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel for prevention of upper-extremity hemodialysis access graft thrombosis
IRCT2013012412256N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clopidogrel in end-stage kidney disease (ESKD) and chronic kidney disease (CKD), sponsored by Kermanshah University of Medical Sciences. Started Oct 2012; status: completed.
02
Drugs
clopidogrel
03
Conditions
end-stage kidney disease (ESKD)chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT2013012412256N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013012412256N1.